Järnerot G, Rolny P, Sandberg-Gertzén H
Gastroenterology. 1985 Nov;89(5):1005-13. doi: 10.1016/0016-5085(85)90201-x.
Two hundred four courses of intensive intravenous treatment were given to 158 patients with ulcerative colitis. The remission rates in the severe, moderate, or mild attacks were 55.7%, 86.9%, and 91.8%. Total colitis had a great impact on the results, especially in severe attacks. Of these patients, 52.8% were operated on within 3 wk. The relapse rate was exponential, and during the first year 48.1% of the patients in remission relapsed. The extent of the colitis, severity of the attack, or duration of intensive intravenous treatment had no influence on the time of relapse. Twelve patients with chronic continuous disease were given intensive intravenous treatment. No long-term benefit was seen in patients with total ulcerative colitis, but half of those with less extensive colitis showed a good to excellent response to treatment.
对158例溃疡性结肠炎患者进行了204个疗程的强化静脉治疗。重度、中度或轻度发作的缓解率分别为55.7%、86.9%和91.8%。全结肠炎对治疗结果有很大影响,尤其是在重度发作时。这些患者中,52.8%在3周内接受了手术。复发率呈指数增长,缓解期患者在第一年有48.1%复发。结肠炎的范围、发作的严重程度或强化静脉治疗的持续时间对复发时间没有影响。12例慢性持续性疾病患者接受了强化静脉治疗。全溃疡性结肠炎患者未观察到长期益处,但病变范围较小的结肠炎患者中有一半对治疗表现出良好至极佳的反应。